1/35
Vocabulary practice flashcards covering cold chain equipment, temperature monitoring parameters, adverse events following immunization (AEFIs), and immunization policy guidelines.
Cold Chain System
A continuous process of maintaining vaccines in a potent state from the manufacturer to the recipient (child and woman of childbearing age).
Freeze-Sensitive Vaccines
Vaccines that suffer irreversible damage and loss of potency when exposed to freezing temperatures, including HepB and liquid Hib (most sensitive), DTP, DT, Td, and TT (least sensitive).
Heat-Sensitive Vaccines
Vaccines that lose potency upon exposure to heat, arranged in decreasing sensitivity from OPV (most sensitive), Measles, BCG, DTP and DT, TT, DTP/HepB, to PCV (least sensitive).
Cold Rooms and Freezer Rooms
Large, specially constructed rooms designed for storing large quantities of vaccines, equipped with dual cooling units (one running, one standby), a 24-hour temperature alarm/recorder, and an automatic backup generator. Cold rooms exist at national and regional levels, whereas freezer rooms exist only at the national level.
Freezer MF314
A specialized cold chain freezer unit used for the bulk storage of antigens and the freezing of icepacks.

Vaccine Refrigerator Arrangement
A standardized protocol where icepacks are kept in the freezing compartment and bottom shelf, OPV and Measles on the top tray, BCG in the middle, TT, DPT+HepB-Hib, and Pneumo on lower shelves, and opened vials kept in a box marked 'use first'.

Cold Box
An insulated container primarily used for vaccine transport and temporary vaccine storage during refrigerator breakdowns, with a cold life that varies according to type, ambient temperature, and opening frequency.

Vaccine Carrier
A portable insulated container used for temporary storage during short-distance vaccine transportation and service delivery, maintaining an approximate cold life of 8hours.

Icepacks
Flat, rectangular plastic containers filled with water or gel used inside cold boxes, vaccine carriers, or refrigerators to maintain temperatures; at least one extra reserve set must always be kept.
Safe Refrigerator Temperature Range
The standard operational temperature range of +2∘C to +8∘C required for storing vaccines, recorded twice daily (morning and evening) including weekends and public holidays.
Evaporator Defrosting Threshold
The thickness of ice buildup on the refrigerator evaporator (6mm to 10mm) that necessitates initiating a manual defrost.
Cold Chain Emergencies
Unplanned events capable of disrupting immunization services, including equipment breakdowns, electrical power failures, shortages of gas, and shortages of spare parts.
Fridge-tag®
An electronic temperature data logger that records and displays daily minimum and maximum temperatures over a 30-day span alongside the refrigerator's current temperature.

Vaccine Cold Chain Monitor
A chemical indicator card packaged with vaccine consignments that changes color across sequential indicator windows (A, B, C, D) when exposed to elevated temperatures over time.

Vaccine Vial Monitor (VVM)
A heat-sensitive label affixed to a vaccine vial that registers cumulative heat exposure over time through an irreversible color shift of the inner square from light to dark.

Freeze Watch Indicator
A monitoring device containing a small vial of liquid dye attached to a card that freezes, fractures, and stains the white backing paper if exposed to temperatures below 0∘C for longer than 1hour.

STOP Watch Refrigerator Monitor
A dual-indicator monitoring card combining a heat-sensitive monitor that irreversibly records temperatures exceeding +10∘C and a freeze indicator that bursts at temperatures below −4∘C.

Shake Test
A physical assessment method used to determine freeze damage by shaking a suspected vial alongside a known correctly stored control vial (such as Tetanus Toxoid) and comparing their sedimentation rates under strong light.
Adverse Events Following Immunization (AEFIs)
Any medical incident occurring in a recipient following vaccination that is presumed to be related to the vaccine until proven otherwise.
Vaccine Reaction
An AEFI caused or precipitated by the inherent biological or physical properties of the vaccine when correctly prepared and administered.
Programme Error
An AEFI caused by human error during vaccine preparation, handling, storage, or clinical administration.
Injection Reaction
An AEFI triggered by anticipation, acute anxiety, or physical pain from the injection procedure itself rather than the vaccine agent (e.g., a vasovagal faint).
Coincidental AEFI
An adverse medical incident that occurs following immunization by chance association, without any causal connection to the administered vaccine.
Serious AEFI
An adverse event following immunization that results in death, is life-threatening, requires or prolongs hospitalization, causes significant disability/incapacity, results in a congenital anomaly, or requires medical intervention to prevent permanent impairment.
Sterile Abscess
A non-purulent, draining fluid mass at the injection site persisting for more than 1month and measuring greater than 2.5cm in diameter, devoid of localized inflammatory signs, and unresponsive to antimicrobial therapy.
Infected Abscess
A purulent fluid lesion at the injection site confirmed by positive Gram stain or culture, displaying classic local signs of inflammation (erythema, warmth, tenderness) and improving under antimicrobial treatment.
Nodule
A firm, small mass of tissue with well-demarcated borders appearing at the injection site without erythema or heat, frequently linked to aluminum-adsorbed vaccines deposited subcutaneously instead of intramuscularly.
Cellulitis
An acute post-immunization skin infection characterized by intense spreading erythema, tenderness to light touch, induration, and substantial local warmth.
Anaphylaxis
A severe, multi-system allergic reaction with onset typically within 5 to 30minutes of injection, characterized by an itchy urticarial rash, angioedema, stridor/wheezing, tachycardia, and progressive hypotension.
Epinephrine Administration for Anaphylaxis
Prompt administration of 0.01ml/kg (maximum 0.5ml) of aqueous epinephrine 1:1000 subcutaneously or intramuscularly in the limb opposite the injection site, repeatable every 20minutes as needed.
Missed Opportunity in Immunization (MOI)
A circumstance in which an eligible child or woman visits a healthcare facility but fails to receive the vaccine dose(s) for which they qualify.
Unit of Vaccines and Immunisation Services (UVIS)
The specialized division within Kenya's Ministry of Health, established on 1st July 2007 from the former KEPI, responsible for overseeing immunization policy, priority vaccines, and national supply logistics.
Fully Immunized Child
Under Kenya's National Policy Guidelines on Immunization, a child who has successfully received all prescribed national schedule antigens and at least one dose of Vitamin A prior to their first birthday.
Multi-Dose Vial Policy (MDVP)
A policy permitting opened vials of liquid vaccines containing preservatives (OPV, TT, HepB, Pentavalent) to be used across subsequent immunization sessions for up to 4weeks, provided the expiry date has not passed, proper cold chain was maintained, the septum was not submerged, aseptic technique was observed, and the VVM has not reached its discard point.
Global Immunization Vision and Strategy (GIVS)
A 2006–2015 strategic framework launched on 25th May 2005 by WHO and UNICEF to reduce vaccine-preventable morbidity and mortality by at least two-thirds compared to 2000 levels.
Global Vaccine Action Plan (GVAP)
A roadmap developed under the Decade of Vaccines (2011–2020) Collaboration to achieve a polio-free world, meet regional elimination goals, and extend equitable immunization coverage across all nations.